Chemoprevention of Colorectal Cancer—With Emphasis on Low-Dose Aspirin and Anticoagulants
<b>Background and Aims:</b> Colorectal cancer (CRC) remains the third most common cancer worldwide and a leading cause of cancer-related death. Chemoprevention through widely used pharmaceutical agents has garnered increasing interest due to its potential cost-effectiveness and accessibi...
Saved in:
| Main Authors: | Arnar Snaer Agustsson, Einar Stefan Bjornsson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/6/811 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemoprevention of Gastric Cancer: Metformin
by: Young-Il Kim, et al.
Published: (2017-12-01) -
Chemoprevention of Gastric Cancer: Non-steroidal Anti-inflammatory Drugs Including Aspirin
by: Kee Don Choi
Published: (2017-12-01) -
Updates in clinical trial-explored chemopreventive agents for cutaneous melanoma: mechanisms affecting melanocytes
by: Gelare Ghajar-Rahimi, et al.
Published: (2025-05-01) -
Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
by: Eun Hye Oh, et al.
Published: (2025-04-01) -
Aspirin‐Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT‐3 Trial
by: Masahiro Natsuaki, et al.
Published: (2024-08-01)